Skip to main content
Smart Investors Daily
SP

OTC · SPHRY

Starpharma Holdings Limited

Healthcare · Biotechnology

$5.35

Up+$0.00 (+0.00%)

Updated Sep 11, 2026, 3:46 AM

SID Score

4.8/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
108.27M
P/E ratio
-15.28
Dividend yield
1.57%
52-week range
$0.47 – $3.60
Volume
1.04K
Avg. volume
1.71K

Price performance

SPHRY price history

1M range · 0 trading sessions · Daily adjusted prices

SPHRY does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest SPHRY news

The latest Smart Investors Daily articles mentioning SPHRY.

SPHRY research

Overview

Company profile and research snapshot.

Company profile

STARPHARMA HLDGS S/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
$2.76
Implied upside
Analysts
SPHRY recent ratings
DateFirmRatingTarget
Oct 31, 2022BELL POTTER SECURITIESBuy
Oct 31, 2022BELL POTTER SECURITIESBuy
Oct 30, 2022BELL POTTER SECURITIESBuy
Sep 30, 2021BELL POTTER SECURITIESBuy
Sep 30, 2021BELL POTTER SECURITIESBuy
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.